1-3 of 3
Laurie A. Milner, MD
Close
Sort by
Journal Articles

Outpatient Administration of High Dose BEAM Chemotherapy As Conditioning for Autologous Stem Cell Transplantation for Lymphoma Results in Fewer Infectious Complications and Improved Survival

Robin M. Reid, MD, Andrea Baran, MS, Paul M. Barr, MD, Michael W. Becker, MD, Steven H. Bernstein, MD, Jonathan W. Friedberg, MD, Jane L. Liesveld, MD, Gordon L. Phillips, MD, Lucy Wedow, FNP, Laurie A. Milner, MD
Journal: Blood
Blood (2014) 124 (21): 3984.
https://doi.org/10.1182/blood.V124.21.3984.3984
Published: 2014
Journal Articles

Late Relapses Following High Dose Chemotherapy and Autologous Stem Cell Transplant in Patients with Diffuse Large B Cell Lymphoma in the Rituximab Era

Carla Casulo, MD, Hunter D Bradley, MD MPH, Megan M. Herr, BS, Ferdous Barlaskar, MD PhD, Andrew Evans, MDPhD, Richard Burack, MDPhD, Jane L. Liesveld, MD, Michael W. Becker, MD, Laurie A. Milner, MD, Paul M. Barr, MD, Jonathan W. Friedberg, MD MMSc
Journal: Blood
Blood (2014) 124 (21): 3999.
https://doi.org/10.1182/blood.V124.21.3999.3999
Published: 2014
Journal Articles

Transgenes Targeted to the HPRT Locus and Expressed from a Tetracycline-Inducible Promoter Are Silenced during Embryonic Stem Cell Differentiation.

Laurie A. Milner, MD, Michael Kyba, PhD, George Q. Daley, MD, PhD, Marlene Balys, MS
Journal: Blood
Blood (2005) 106 (11): 3618.
https://doi.org/10.1182/blood.V106.11.3618.3618
Published: 2005